Paolo Calabrò

Showing 1-3 of 3 articles

Coronary interventions

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a contemporary reappraisal

Pelliccia F, Niccoli G, Gragnano F, Limongelli G, Moscarella E, Andò G, Esposito A, Stabile E, Ussia G, Tarantini G, Gimeno JR, Elliott P, Calabrò P

August 29, 2019 | 10.4244/EIJ-D-18-00959

One-year clinical outcomes after unrestricted implantation of the Absorb bioresorbable scaffold (RAI registry)

Ielasi A, Cortese B, Moscarella E, Loi B, Tarantini G, Varricchio A, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Pietro Mazzarotto P, Tespili M, Orrego P, Corrado D, Steffenino G

August 3, 2018 | 10.4244/EIJ-D-17-00443

Coronary interventions

Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

De Servi S, Crimi G, Calabrò P, Piscione F, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Barozzi C, Tomasi L, Della Riva D, Angiolillo D, Palmerini T

June 20, 2016 | 10.4244/EIJV12I3A51

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Valvular disease